StockData

Dow vs Eastman Chemical

DOW and EMN side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DOW and EMN compare

Dow is the larger company, worth 3.2 times as much as Eastman Chemical ($23.9B against $7.4B).

Dow grew revenue faster over the last twelve months (4.2% versus 0.27% for Eastman Chemical).

Both pay dividends: Dow yields 4.2% and Eastman Chemical 5.2%.

Eastman Chemical scores higher on the StockData Score (16 against 8 for Dow), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDOWEMN
Size and price
Market cap$23.9B$7.4B
Share price$33.04$65.03
Change, 1 year49.0%6.7%
Change, 5 years−42.4%−42.5%
Beta (5Y)0.711.10
Employees35K13K
StockData Score
Total score816 (better)
Valuation score25 (better)
Growth score11
Performance score02 (better)
Health score3 (better)2
Dividend score26 (better)
Valuation
P/E–12.0×
P/S0.6× (better)0.8×
P/B1.5×1.2× (better)
EV/EBITDA12.2×–
P/FCF–15.9×
FCF yield–6.3%
Fair value$37.55$92.79
Margin of safety12.0%29.9% (better)
Growth
Revenue growth (TTM)4.2% (better)0.27%
Revenue growth, 5Y average0.73% (better)0.65%
Net income growth (TTM)–−13.3%
EPS growth (TTM)–−12.3%
EPS growth, 5Y average–3.2%
Profitability
Gross margin11.1%20.6% (better)
Net margin–6.9%
FCF margin–5.2%
Return on equity–10.4%
Financial health
Debt / equity1.080.83 (better)
Net debt / EBITDA4.19–
Current ratio1.76 (better)1.57
Altman Z-score1.582.13 (better)
Piotroski F-score–5
Dividends and buybacks
Dividend yield4.2%5.2% (better)
Payout ratio–61.1%
Years of dividend growth016 (better)
Dividend growth, 5Y average0.00%4.5% (better)
Shareholder yield4.2%5.2% (better)
Ownership
Held by institutions77.9%94.1%
Held by insiders0.28%0.83%
Insider net buying, 12 months–−$206K
Superinvestors holding–1
Short interest, % of float3.8%4.9%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.